Wall Street Analysts Largely Favor Johnson & Johnson with Buy/Hold Ratings
JNJ•Johnson & Johnson currently holds predominantly Buy or Hold ratings from sell-side analysts, with only a minority expressing skepticism. This analysis evaluates the historical impact of these bullish recommendations on J&J’s share price and questions whether rating revisions meaningfully influence long-term investor returns.
1. Analyst Recommendations and Impact
A broad consensus among brokerage analysts currently favors Johnson & Johnson, with most recommending Buy or Hold. Historical patterns indicate that rating revisions can cause short-term price fluctuations but rarely align with full-year returns, highlighting the importance of examining earnings momentum and dividend growth alongside sell-side opinions.
